Celastrol Attenuates Inflammatory and Neuropathic Pain Mediated by Cannabinoid Receptor Type 2

Identification of CB1/CB2 Ligands from Zanthoxylum bungeanum

(2013) Katina S. S. Dossou et al.   JOURNAL OF NATURAL PRODUCTS

Celastrol Prevents Atherosclerosis via Inhibiting LOX-1 and Oxidative Stress

(2013) Lei Gu et al.   PLoS One

“Redundancy” of Endocannabinoid Inactivation: New Challenges and Opportunities for Pain Control

(2012) Fabiana Piscitelli et al.   ACS Chemical Neuroscience

The monoacylglycerol lipase inhibitor JZL184 attenuates LPS-induced increases in cytokine expression in the rat frontal cortex and plasma: differential mechanisms of action

(2012) DM Kerr et al.   BRITISH JOURNAL OF PHARMACOLOGY

Celastrus and Its Bioactive Celastrol Protect against Bone Damage in Autoimmune Arthritis by Modulating Osteoimmune Cross-talk

(2012) Siddaraju M. Nanjundaiah et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The monoacylglycerol lipase inhibitor JZL184 suppresses inflammatory pain in the mouse carrageenan model

(2012) Sudeshna Ghosh et al.   LIFE SCIENCES

Euphol, a tetracyclic triterpene produces antinociceptive effects in inflammatory and neuropathic pain: The involvement of cannabinoid system

(2012) Rafael Cypriano Dutra et al.   NEUROPHARMACOLOGY

Dynamic changes to the endocannabinoid system in models of chronic pain

(2012) D. Rani Sagar et al.   PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES

Tripterygium wilfordii bioactive compounds as anticancer and anti-inflammatory agents

(2011) Kwong-Fai Wong et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

The Role of Endocannabinoids in Pain Modulation and the Therapeutic Potential of Inhibiting their Enzymatic Degradation

(2011) L. J. Alvarez-Jaimes et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Celastrus-derived Celastrol Suppresses Autoimmune Arthritis by Modulating Antigen-induced Cellular and Humoral Effector Responses

(2011) Shivaprasad H. Venkatesha et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Molecular targets of celastrol derived from Thunder of God Vine: Potential role in the treatment of inflammatory disorders and cancer

(2010) Radhamani Kannaiyan et al.   CANCER LETTERS

Reduction of β-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease

(2010) Daniel Paris et al.   Journal of Neuroinflammation

Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment

(2010) Ralf Baron et al.   LANCET NEUROLOGY

Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression

(2009) Fabrício A. Moreira et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Emerging strategies for exploiting cannabinoid receptor agonists as medicines

(2009) Roger G Pertwee   BRITISH JOURNAL OF PHARMACOLOGY

Discovery of Potent and Reversible Monoacylglycerol Lipase Inhibitors

(2009) Alvin R. King et al.   CHEMISTRY & BIOLOGY

Celastrol suppresses allergen-induced airway inflammation in a mouse allergic asthma model

(2009) Dae Yong Kim et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Cannabinoids as pharmacotherapies for neuropathic pain: From the bench to the bedside

(2009) Elizabeth J. Rahn et al.   Neurotherapeutics

Beta-caryophyllene is a dietary cannabinoid

(2008) Jürg Gertsch et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Cannabinoid CB2receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain

(2007) J Guindon et al.   BRITISH JOURNAL OF PHARMACOLOGY